Compagnie Lombard Odier SCmA Grows Stake in SPDR S&P Biotech ETF (NYSEARCA:XBI)

Compagnie Lombard Odier SCmA grew its position in shares of SPDR S&P Biotech ETF (NYSEARCA:XBI) by 51.7% in the fourth quarter, Holdings Channel reports. The firm owned 3,640 shares of the exchange traded fund’s stock after purchasing an additional 1,240 shares during the period. Compagnie Lombard Odier SCmA’s holdings in SPDR S&P Biotech ETF were worth $328,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently made changes to their positions in the company. CWM LLC grew its position in SPDR S&P Biotech ETF by 22.0% in the third quarter. CWM LLC now owns 10,239 shares of the exchange traded fund’s stock worth $1,012,000 after acquiring an additional 1,849 shares in the last quarter. Creative Planning grew its position in SPDR S&P Biotech ETF by 15.6% in the third quarter. Creative Planning now owns 29,114 shares of the exchange traded fund’s stock worth $2,876,000 after acquiring an additional 3,920 shares in the last quarter. Vontobel Holding Ltd. grew its position in SPDR S&P Biotech ETF by 23.2% in the third quarter. Vontobel Holding Ltd. now owns 6,542 shares of the exchange traded fund’s stock worth $646,000 after acquiring an additional 1,233 shares in the last quarter. Global Retirement Partners LLC grew its position in SPDR S&P Biotech ETF by 135.1% in the third quarter. Global Retirement Partners LLC now owns 5,744 shares of the exchange traded fund’s stock worth $568,000 after acquiring an additional 3,301 shares in the last quarter. Finally, Trust Co. of Vermont grew its position in SPDR S&P Biotech ETF by 4.7% in the third quarter. Trust Co. of Vermont now owns 3,058 shares of the exchange traded fund’s stock worth $302,000 after acquiring an additional 138 shares in the last quarter.

SPDR S&P Biotech ETF Stock Performance

Shares of NYSEARCA:XBI opened at $91.41 on Friday. SPDR S&P Biotech ETF has a 52-week low of $81.14 and a 52-week high of $105.47. The firm has a fifty day moving average of $91.77 and a 200 day moving average of $96.15. The firm has a market capitalization of $6.97 billion, a PE ratio of 11.47 and a beta of 1.11.

SPDR S&P Biotech ETF Company Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges.